BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rahmanian-Devin P, Baradaran Rahimi V, Jaafari MR, Golmohammadzadeh S, Sanei-Far Z, Askari VR. Noscapine, an Emerging Medication for Different Diseases: A Mechanistic Review. Evid Based Complement Alternat Med 2021;2021:8402517. [PMID: 34880922 DOI: 10.1155/2021/8402517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pragyandipta P, Naik MR, Bastia B, Naik PK. Development of 9-(N-arylmethylamino) congeners of noscapine: the microtubule targeting drugs for the management of breast cancer. 3 Biotech 2023;13:38. [PMID: 36636578 DOI: 10.1007/s13205-022-03445-3] [Reference Citation Analysis]
2 Zhang M, Zhao M, Wang Y, Chen L, Li G, Liu B, You X, Sun W, Hong L. Synthesis and Biological Evaluation of Phthalideisoquinoline Derivatives. J Org Chem 2023. [PMID: 36651751 DOI: 10.1021/acs.joc.2c02702] [Reference Citation Analysis]
3 Naseri G, Raasch H, Charpentier E, Erhardt M. A regulatory toolkit of arabinose-inducible artificial transcription factors for Gram-negative bacteria.. [DOI: 10.1101/2022.11.30.518220] [Reference Citation Analysis]
4 Rampogu S, Balasubramaniyam T, Lee J. Phytotherapeutic applications of alkaloids in treating breast cancer. Biomedicine & Pharmacotherapy 2022;155:113760. [DOI: 10.1016/j.biopha.2022.113760] [Reference Citation Analysis]
5 Xu W, Kotheeranurak V, Zhang H, Feng J, Liu J, Chen C, Lin G, Rui G. Identification of the circRNA–miRNA–mRNA regulatory network in osteoarthritis using bioinformatics analysis. Front Genet 2022;13:994163. [DOI: 10.3389/fgene.2022.994163] [Reference Citation Analysis]
6 Nourbakhsh F, Mousavi SH, Rahmanian-devin P, Baradaran Rahimi V, Rakhshandeh H, Askari VR. Topical Formulation of Noscapine, a Benzylisoquinoline Alkaloid, Ameliorates Imiquimod-Induced Psoriasis-Like Skin Lesions. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-19. [DOI: 10.1155/2022/3707647] [Reference Citation Analysis]
7 Taherzadeh D, Baradaran Rahimi V, Amiri H, Ehtiati S, Yahyazadeh R, Hashemy SI, Askari VR. Acetyl-11-Keto-β-Boswellic Acid (AKBA) Prevents Lipopolysaccharide-Induced Inflammation and Cytotoxicity on H9C2 Cells. Evid Based Complement Alternat Med 2022;2022:2620710. [PMID: 35399644 DOI: 10.1155/2022/2620710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]